Can gut microbes predict efficacy and toxicity of combined immune checkpoint blockade?
- PMID: 34637746
- DOI: 10.1016/j.ccell.2021.09.013
Can gut microbes predict efficacy and toxicity of combined immune checkpoint blockade?
Abstract
A recent report in Nature Medicine pinpoints a role for gut microbiota in response and toxicity to combined immune checkpoint blockade targeting CTLA-4 and PD-1. This emergent study provides insights that can be used to leverage microbiota in the design of anticancer therapies to mitigate toxicity while enhancing efficacy.
Published by Elsevier Inc.
Comment on
-
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade.Nat Med. 2021 Aug;27(8):1432-1441. doi: 10.1038/s41591-021-01406-6. Epub 2021 Jul 8. Nat Med. 2021. PMID: 34239137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources